KaliVir Immunotherapeutics

Series-A
kalivir.com Biotech & Healthcare
Total Funding $14M
Latest Round $14M Series-A
Last Announced Aug 19, 2026
Investors Undisclosed
Decision Makers 4 Verified

About KaliVir Immunotherapeutics

multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website kalivir.com
Domain Registered Date Jun 19, 2019

Social & Network Presence

X / Twitter Profile @kalivir_immuno (74 followers) Created on Jul 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $14,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    X account created (@kalivir_immuno)

    74 followers

  3. Milestone

    Website domain registered

    kalivir.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for KaliVir Immunotherapeutics.

Funding History

1 Round
Series-A · Aug 19, 2026

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts